BRODSKY & SMITH INVESTOR ALERT: Announcing Investigations into Qorvo, Inc. (Nasdaq – QRVO), First Foundation Inc. (NYSE – FFWM), Akero Therapeutics, Inc. (Nasdaq - AKRO), and CoreCard Corporation (NYSE - CCRD)

Qorvo Acquisition Investigation: Qorvo, Inc. is set to be acquired by Skyworks for $32.50 in cash and 0.960 shares of Skyworks per Qorvo share, with investigations into whether the Qorvo Board breached fiduciary duties by not ensuring a fair process and deal value for shareholders.

First Foundation Merger Inquiry: First Foundation Inc. will merge with FirstSun Capital Bancorp in an all-stock deal, raising concerns about the First Foundation Board's fiduciary duties and the fairness of the deal for its shareholders.

Akero Therapeutics Acquisition Scrutiny: Akero Therapeutics, Inc. is being acquired by Novo Nordisk for $54.00 per share plus a contingent value right, with investigations focusing on the Board's adherence to fiduciary duties and the fairness of the transaction for shareholders.

CoreCard Corporation Merger Investigation: CoreCard Corporation will merge with Euronet in a stock-for-stock transaction valued at approximately $248 million, prompting inquiries into whether the CoreCard Board fulfilled its fiduciary responsibilities and ensured fair value for shareholders.